Cardio-metabolic disease in India-the up-coming tsunami.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Burden of subclinical coronary atherosclerosis among asymptomatic adults: the REACH-Rural India Study.The Lancet regional health. Southeast Asia · 2026
   Article
2. The burgeoning cardiovascular disease epidemic in Indians - perspectives on contextual factors and potential solutions.The Lancet regional health. Southeast Asia · 2023
   Review
3. Cognitive Function and Cardiometabolic-Inflammatory Risk Factors Among Older Indians and Americans.Journal of the American Geriatrics Society · 2020
   Article
4. Association between Serum Calcium and Risk of Cardiometabolic Disease among Community-dwelling Adults in Taiwan.Scientific reports · 2020
   Article
5. Global perspectives on cardiometabolic risk and cardiovascular disease: from basic science to bedside.Annals of translational medicine · 2018
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.